RESEARCH
[Publication] Commensal consortia decolonize Enterobacteriaceae via ecological control
September 19, 2024

Fig.1: Elaboration of an 18-strain-consortium capable of decolonizing Klebsiella.
Title |
Commensal consortia decolonize Enterobacteriaceae via ecological control |
---|---|
Authors | Munehiro Furuichi [1],[2],[14]; Takaaki Kawaguchi [1],[2],[14]; Marie-Madlen Pust [3],[4],[14]; Keiko Yasuma-Mitobe [1],[14]; Damian R. Plichta [3]; Naomi Hasegawa [1]; Takashi Ohya [1],[2]; Shakti K. Bhattarai [5]; Satoshi Sasajima [1]; Yoshimasa Aoto [6]; Timur Tuganbaev [1],[7]; Mizuki Yaginuma [1]; Masahiro Ueda [2],[6]; Nobuyuki Okahashi [2],[8],[9]; Kimiko Amafuji [6]; Yuko Kiridoshi [6]; Kayoko Sugita [1]; Martin Stražar [3]; Julian Avila-Pacheco [3]; Kerry Pierce [3]; Clary B. Clish [3]; Ashwin N. Skelly [1]; Masahira Hattori [2],[10]; Nobuhiro Nakamoto [11]; Silvia Caballero [12]; Jason M. Norman [12]; Bernat Olle [12]; Takeshi Tanoue [1],[2]; Wataru Suda [2],[10]; Makoto Arita [2],[7],[9]; Vanni Bucci [5]; Koji Atarashi [1],[2],[7]; Ramnik J. Xavier [3],[4],[13] & Kenya Honda [1],[2],[7] |
DOI | https://doi.org/10.1038/s41586-024-07960-6 |
Journal | Nature |
Vol/Num/Page | 633, 878–886 (2024) |
Published Date | 18 September 2024 |
Affiliations:
[1] Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
[2] RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
[3] Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
[4] Center for Computational and Integrative Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
[5] Department of Microbiology and Physiological Systems, Program in Microbiome Dynamics, UMass Chan Medical School, Worcester, MA, USA.
[6] JSR-Keio University Medical and Chemical Innovation Center, Keio University School of Medicine, Tokyo, Japan.
[7] Human Biology Microbiome Quantum Research Center (Bio2Q), Keio University, Tokyo, Japan.
[8] Department of Bioinformatic Engineering, Graduate School of Information Science and Technology, Osaka University, Osaka, Japan.
[9] Division of Physiological Chemistry and Metabolism, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.
[10] Cooperative Major in Advanced Health Science, Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan.
[11] Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
[12] Vedanta Biosciences, Cambridge, MA, USA.
[13] Department of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA.
[14] These authors contributed equally: Munehiro Furuichi, Takaaki Kawaguchi, Marie-Madlen Pust, Keiko Yasuma-Mitobe.
More Bio2Q News
WPI-Bio2Q Social Event (2025.9.29)
WPI-Bio2Q held a social event at Keio University's Shinanomachi Campus. Date & Time: Monday, September 29, 2025, 12:00-13:00 Venue: ...
【Event】Keio Alumni Association Convention 2025
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will give a presentation at the Keio Alumni Association Convent...
Visit to Bio2Q by Dr. Hitoshi Nakagama, President of the Japan Agency for Medica...
On September 22, 2025, Dr. Hitoshi Nakagama, President of the Japan Agency for Medical Research and Development (AMED), visited Bio2Q. Admi...
Bio2Q Research Internship
The Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) is offering a research internship as part of the STaMP prog...
Newsletter “Bio2Q Connect” (Vol. 2, Issue 9)
We are delighted to share with you Vol. 2, Issue 9 of WPI-Bio2Q Newsletter “Bio2Q Connect”. Major topics of this issue include: Open S...